International patent classifier
381-1-003 · 76880 yozuv
| Id Eng | Name | |
|---|---|---|
| A61K0031452500 | containing a five-membered ring with oxygen as a ring hetero atom | Learn more |
| A61K0031453000 | containing a six-membered ring with oxygen as a ring hetero atom | Learn more |
| A61K0031453500 | containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen | Learn more |
| A61K0031454000 | containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone | Learn more |
| A61K0031454500 | containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine | Learn more |
| A61K0031455000 | Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides | Learn more |
| A61K0031460000 | 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine | Learn more |
| A61K0031465000 | Nicotine; Derivatives thereof | Learn more |
| A61K0031470000 | Quinolines; Isoquinolines | Learn more |
| A61K0031470400 | 2-Quinolinones, e.g. carbostyril | Learn more |
| A61K0031470600 | 4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine | Learn more |
| A61K0031470900 | Non-condensed quinolines containing further heterocyclic rings | Learn more |
| A61K0031472000 | Non-condensed isoquinolines, e.g. papaverine | Learn more |
| A61K0031472500 | containing further heterocyclic rings | Learn more |
| A61K0031473000 | ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines | Learn more |
| A61K0031473800 | ortho- or peri-condensed with heterocyclic ring systems | Learn more |
| A61K0031474100 | condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline | Learn more |
| A61K0031474300 | condensed with ring systems having sulfur as a ring hetero atom | Learn more |
| A61K0031474500 | condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines (yohimbine derivatives, vinblastine A61K0031475000;ergoline derivatives A61K0031480000) | Learn more |
| A61K0031474700 | spiro-condensed | Learn more |
| A61K0031474800 | forming part of bridged ring systems (strychnine A61K0031475000;morphinan derivatives A61K0031485000) | Learn more |
| A61K0031475000 | having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine (vincamine A61K0031437500) | Learn more |
| A61K0031480000 | Ergoline derivatives, e.g. lysergic acid, ergotamine | Learn more |
| A61K0031485000 | Morphinan derivatives, e.g. morphine, codeine | Learn more |
| A61K0031490000 | Cinchonan derivatives, e.g. quinine | Learn more |
| A61K0031495000 | having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine (A61K0031480000 takes precedence) | Learn more |
| A61K0031496000 | Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene | Learn more |
| A61K0031496500 | Non-condensed pyrazines | Learn more |
| A61K0031497000 | containing further heterocyclic rings | Learn more |
| A61K0031498000 | Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine | Learn more |
| A61K0031498500 | Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems | Learn more |
| A61K0031499000 | Spiro-condensed pyrazines or piperazines | Learn more |
| A61K0031499500 | Pyrazines or piperazines forming part of bridged ring systems | Learn more |
| A61K0031500000 | Pyridazines; Hydrogenated pyridazines | Learn more |
| A61K0031501000 | not condensed and containing further heterocyclic rings | Learn more |
| A61K0031502000 | ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine | Learn more |
| A61K0031502500 | ortho- or peri-condensed with heterocyclic ring systems | Learn more |
| A61K0031503000 | spiro-condensed | Learn more |
| A61K0031504000 | forming part of bridged ring systems | Learn more |
| A61K0031505000 | Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim | Learn more |
| A61K0031506000 | not condensed and containing further heterocyclic rings | Learn more |
| A61K0031510000 | Thiamines, e.g. vitamin B1 | Learn more |
| A61K0031513000 | having oxo groups directly attached to the heterocyclic ring, e.g. cytosine | Learn more |
| A61K0031515000 | Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital | Learn more |
| A61K0031517000 | ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine | Learn more |
| A61K0031519000 | ortho- or peri-condensed with heterocyclic rings | Learn more |
| A61K0031520000 | Purines, e.g. adenine | Learn more |
| A61K0031522000 | having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir | Learn more |
| A61K0031525000 | Isoalloxazines, e.g. riboflavins, vitamin B2 | Learn more |
| A61K0031527000 | spiro-condensed | Learn more |
Yangilangan: 23.12.2021